Akba Q4 2025 Earnings Akebia Therapeutics Inc. Misses Eps Estimates No Revenue 20260403 1 Is Acadian Aami Stock Risky Now Price At 61.60 Down 0.41 20260410 Mram Stock In Focus Buying Pressure Builds 20260403 1 Daily Market Overview S And P 500 Nasdaq Edge Higher Dow Dips Modestly 20260403 1 Beam Stock Analysis Beam Therapeutics Inc. Biotech Stock Gains 1.82 Percent At 24.66 Level 20260403 1